Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ONTF
|
Goldman Sachs Group Inc |
BUY
Open market or private purchase
|
Indirect | 87,800 Added 21.81% |
$6,553,392
$74.64 p/Share
|
Feb 03
2021 |
BFST
|
Keith Alexis Tillage
Director |
BUY
Open market or private purchase
|
Direct | 50 Added 16.67% |
$1,023
$20.46 p/Share
|
Feb 03
2021 |
ONTF
|
Goldman Sachs Group Inc |
BUY
Open market or private purchase
|
Indirect | 6,350 Added 1.02% |
$470,535
$74.1 p/Share
|
Feb 03
2021 |
NCNO
|
Salesforce.Com, Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 44,083 Reduced 0.15% |
$3,206,157
$72.73 p/Share
|
Feb 03
2021 |
AMP
|
Colin Moore
EVP & Global CIO |
SELL
Open market or private sale
|
Direct | 44,068 Reduced 43.27% |
$8,926,855
$202.57 p/Share
|
Feb 03
2021 |
AMP
|
Karen Wilson Thissen
Executive VP and GC |
SELL
Open market or private sale
|
Direct | 1,307 Reduced 8.5% |
$267,857
$204.94 p/Share
|
Feb 03
2021 |
AMP
|
William F Truscott
CEO, GLOBAL ASSET MANAGEMENT |
SELL
Open market or private sale
|
Indirect | 12,002 Reduced 27.0% |
$2,443,727
$203.61 p/Share
|
Feb 03
2021 |
TEN
|
Icahn Carl C
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 208,478 Reduced 2.69% |
$2,278,665
$10.93 p/Share
|
Feb 03
2021 |
RSSS
|
12 West Capital Management LP |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 3.59% |
$253,000
$2.53 p/Share
|
Feb 03
2021 |
TWTR
|
Matthew Derella
Customers Lead |
SELL
Open market or private sale
|
Direct | 21,438 Reduced 7.2% |
$1,172,873
$54.71 p/Share
|
Feb 03
2021 |
JAZZ
|
Bruce C Cozadd
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 250 Reduced 0.08% |
$40,000
$160.0 p/Share
|
Feb 03
2021 |
FTNT
|
John Whittle
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 3,577 Reduced 100.0% |
$550,250
$153.83 p/Share
|
Feb 03
2021 |
NTLA
|
John M Leonard
President and CEO |
SELL
Open market or private sale
|
Direct | 67,856 Reduced 9.94% |
$4,919,560
$72.5 p/Share
|
Feb 03
2021 |
PGNY
|
David J Schlanger
Executive Chairman |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 100.0% |
$2,427,500
$48.55 p/Share
|
Feb 03
2021 |
PGNY
|
Peter Anevski
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 21,000 Reduced 3.38% |
$1,020,390
$48.59 p/Share
|
Feb 03
2021 |
ERII
|
Rodney Clemente
SVP, Water |
SELL
Open market or private sale
|
Direct | 9,748 Reduced 17.94% |
$135,302
$13.88 p/Share
|
Feb 03
2021 |
ERII
|
Farshad Ghasripoor
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 9,121 Reduced 12.27% |
$126,599
$13.88 p/Share
|
Feb 03
2021 |
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.72% |
$246,000
$8.2 p/Share
|
Feb 03
2021 |
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.72% |
$246,000
$8.2 p/Share
|
Feb 03
2021 |
INO
|
Jong Joseph Kim
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 62,500 Reduced 5.48% |
$890,000
$14.24 p/Share
|
Feb 03
2021 |
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$24,080
$6.02 p/Share
|
Feb 03
2021 |
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.24% |
$24,080
$6.02 p/Share
|
Feb 03
2021 |
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$24,080
$6.02 p/Share
|
Feb 03
2021 |
CRTX
|
Casey Lynch
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.21% |
$837,000
$41.85 p/Share
|
Feb 03
2021 |
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,295 Reduced 100.0% |
$34,745
$26.83 p/Share
|
Feb 03
2021 |
UMPQ
|
David F Shotwell
EVP/Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 379 Reduced 0.39% |
$5,776
$15.24 p/Share
|
Feb 03
2021 |
AGM
|
Zions Bancorporation, National Association /Ut/
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.65% |
$765,600
$76.56 p/Share
|
Feb 03
2021 |
TVTX
|
Peter Heerma
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 563 Reduced 0.98% |
$16,276
$28.91 p/Share
|
Feb 03
2021 |
MORF
|
Robert E Farrell Jr
SVP Finance and CAO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 45.55% |
$574,800
$38.32 p/Share
|
Feb 03
2021 |
GBL
|
Mario J Gabelli
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 800 Reduced 0.04% |
$15,536
$19.42 p/Share
|
Feb 03
2021 |
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 8.41% |
$94,380
$47.19 p/Share
|
Feb 03
2021 |
EMED
|
Donald J Steinberg
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 0.16% |
$2,460
$0.41 p/Share
|
Feb 03
2021 |
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$19,037,782
$332.84 p/Share
|
Feb 03
2021 |
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 44,750 Reduced 32.74% |
$11,937,510
$266.76 p/Share
|
Feb 03
2021 |
FIBK
|
Jeremy Scott
Director |
SELL
Open market or private sale
|
Indirect | 10,223 Reduced 10.69% |
$409,022
$40.01 p/Share
|
Feb 03
2021 |
FIBK
|
Susan Scott Heyneman
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 17.57% |
$1,197,000
$39.9 p/Share
|
Feb 03
2021 |
TVTX
|
Noah L. Rosenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,813 Reduced 3.95% |
$52,414
$28.91 p/Share
|
Feb 03
2021 |
TVTX
|
William E. Rote
Chief Research Officer |
SELL
Open market or private sale
|
Direct | 3,625 Reduced 8.85% |
$104,799
$28.91 p/Share
|
Feb 03
2021 |
TVTX
|
Elizabeth E Reed
Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct | 3,175 Reduced 7.77% |
$91,789
$28.91 p/Share
|
Feb 03
2021 |
TVTX
|
Laura Clague
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,625 Reduced 10.11% |
$104,799
$28.91 p/Share
|
Feb 03
2021 |
TVTX
|
Eric M Dube
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 2,406 Reduced 1.59% |
$69,557
$28.91 p/Share
|
Feb 03
2021 |
AMK
|
Natalie Grace Wolfsen
EVP, Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 22,846 Reduced 6.35% |
$526,143
$23.03 p/Share
|
Feb 03
2021 |
BMRC
|
Elizabeth Reizman
Executive Vice President |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 3.74% |
$37,640
$37.64 p/Share
|
Feb 03
2021 |
FLWS
|
Thomas G Hartnett
President |
SELL
Open market or private sale
|
Direct | 20,759 Reduced 11.25% |
$622,978
$30.01 p/Share
|
Feb 03
2021 |
SPRO
|
Aquilo Capital Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 29,354 Reduced 0.75% |
$557,139
$18.98 p/Share
|
Feb 03
2021 |
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.61% |
$1,565,100
$156.51 p/Share
|
Feb 03
2021 |
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 2,768 Reduced 0.15% |
$69,366
$25.06 p/Share
|
Feb 03
2021 |
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.42% |
$480,750
$19.23 p/Share
|
Feb 03
2021 |
TXN
|
Richard K Templeton
Chairman |
SELL
Open market or private sale
|
Direct | 112,500 Reduced 18.08% |
$19,351,124
$172.01 p/Share
|
Feb 03
2021 |
HARP
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 41,922 Reduced 1.17% |
$847,244
$20.21 p/Share
|
Feb 03
2021 |